Biotech Set To Continue Outperformance

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, December 29, 2021

A California-based biotech company looks like it’s seeing its shares bid up this premarket following yesterday’s strong performance and announcement that the company was awarded a landmark patent for cancer and COVID-19 treatment. Shares of Therapeutic Solutions International Inc. (OTCPK:TSOI) appear to be in high demand as we head into the final fifteen minutes of premarket.

Therapeutic Solutions International Inc. focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces ProJuvenol, a synergistic blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality, Emvolio, Inc. which develops products that can be used together to attack cancer as different levels, and sandbox dental labs, Inc. consists of dental laboratory to manufacture and fill prescriptions from dentist.

Traders appear to be bullish on this small cap this morning as shares are bid up at $0.051/share (+4.29% implied open for sellers). This implied move would come just one session following an incredible rally as shares went on to close up at $0.0489 (+135.10%) on Tuesday.

Copyright © 2021 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.